Title of Invention

IFOSFAMIDE COMPOSITIONS FOR PARENTERAL ADMINISTRATION

Abstract The present invention provides stable, clear, aqueous Ifosfamide compositions for parenteral administration having reduced dose dependent toxicities of Ifosfamide. Also the compositions have reduced urotoxicity over and above the concomitant use of the uroprotective agent, Mesna. Aqueous compositions of Ifosfamide can be prepared at a concentration as high as 1100mg/ml.
Full Text N/A

Documents:

344-mum-2004-abstract(22-03-2004).doc

344-mum-2004-abstract(22-03-2004).pdf

344-mum-2004-claims(granted)-(22-03-2004).doc

344-mum-2004-claims(granted)-(22-03-2004).pdf

344-mum-2004-correspondence(16-01-2008).pdf

344-mum-2004-correspondence(ipo)-(03-08-2007).pdf

344-mum-2004-form 1(22-03-2004).pdf

344-mum-2004-form 18(28-12-2006).pdf

344-mum-2004-form 2(granted)-(22-03-2004).doc

344-mum-2004-form 2(granted)-(22-03-2004).pdf

344-mum-2004-form 26(22-03-2004).pdf

344-mum-2004-form 26(28-03-2004).pdf

344-mum-2004-form 26(28-12-2006).pdf

344-mum-2004-form 3(22-03-2004).pdf


Patent Number 216384
Indian Patent Application Number 344/MUM/2004
PG Journal Number 13/2008
Publication Date 28-Mar-2008
Grant Date 12-Mar-2008
Date of Filing 22-Mar-2004
Name of Patentee BHARAT SERUMS & VACCINES LTD
Applicant Address ROAD NO. 27, W AGLE ESTATE, THANE - 400 604,
Inventors:
# Inventor's Name Inventor's Address
1 DR. DAFTARY GAUTAM VINOD BHARAT SERUMS & VACCINES LTD., ROAD NO. 27, WAGLE ESTATE, THANE - 400 604,
2 PAI SRIKANTH ANNAPPA BHARAT SERUMS & VACCINES LTD., ROAD NO. 27, WAGLE ESTATE, THANE - 400 604, MAHARASHTRA, INDIA.
3 RIVANKAR SANGEETA HANURMESH BHARAT SERUMS & VACCINES LTD., ROAD NO. 27, WAGLE ESTATE, THANE - 400 604, MAHARASHTRA, INDIA.
4 PRAVEEN KUMAR SUBBAPPA BHARAT SERUMS & VACCINES LTD., ROAD NO. 27, WAGLE ESTATE, THANE - 400 604, MAHARASHTRA, INDIA.
PCT International Classification Number A61K31/00 C07D215/16
PCT International Application Number N/A
PCT International Filing date
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 NA